These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12777798)

  • 1. Structural characterization and comparison of RGD cell-adhesion recognition sites engineered into streptavidin.
    Le Trong I; McDevitt TC; Nelson KE; Stayton PS; Stenkamp RE
    Acta Crystallogr D Biol Crystallogr; 2003 May; 59(Pt 5):828-34. PubMed ID: 12777798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constrained cell recognition peptides engineered into streptavidin.
    McDevitt TC; Nelson KE; Stayton PS
    Biotechnol Prog; 1999; 15(3):391-6. PubMed ID: 10356256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
    Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
    J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.
    Katagiri YU; Murakami M; Mori K; Iizuka J; Hara T; Tanaka K; Jia WY; Chambers AF; Uede T
    J Cell Biochem; 1996 Jul; 62(1):123-31. PubMed ID: 8836881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro.
    Grzesik WJ; Robey PG
    J Bone Miner Res; 1994 Apr; 9(4):487-96. PubMed ID: 7518179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembling multimeric integrin alpha5beta1 ligands for cell attachment and spreading.
    Kreiner M; Li Z; Beattie J; Kelly SM; Mardon HJ; van der Walle CF
    Protein Eng Des Sel; 2008 Sep; 21(9):553-60. PubMed ID: 18515822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of integrin α5β1, fibronectin, and their complex reveal sites of interaction and conformational change.
    Su Y; Iacob RE; Li J; Engen JR; Springer TA
    J Biol Chem; 2022 Sep; 298(9):102323. PubMed ID: 35931112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and functional evaluation of RGD-modified streptavidin targeting to integrin-expressing melanoma cells.
    Syrkina MS; Shirokov DA; Rubtsov MA; Kadyrova EL; Veiko VP; Manuvera VA
    Protein Eng Des Sel; 2013 Feb; 26(2):143-50. PubMed ID: 23161915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins.
    Takagi J
    Biochem Soc Trans; 2004 Jun; 32(Pt3):403-6. PubMed ID: 15157147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering cell adhesive surfaces that direct integrin alpha5beta1 binding using a recombinant fragment of fibronectin.
    Cutler SM; García AJ
    Biomaterials; 2003 May; 24(10):1759-70. PubMed ID: 12593958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved affinity of engineered streptavidin for the Strep-tag II peptide is due to a fixed open conformation of the lid-like loop at the binding site.
    Korndörfer IP; Skerra A
    Protein Sci; 2002 Apr; 11(4):883-93. PubMed ID: 11910031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.
    Kimura RH; Levin AM; Cochran FV; Cochran JR
    Proteins; 2009 Nov; 77(2):359-69. PubMed ID: 19452550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain.
    Stubbs JT; Mintz KP; Eanes ED; Torchia DA; Fisher LW
    J Bone Miner Res; 1997 Aug; 12(8):1210-22. PubMed ID: 9258751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL; Giachelli CM
    Exp Cell Res; 1998 Jul; 242(1):351-60. PubMed ID: 9665832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD-mutants of B-lymphotropic polyomavirus capsids specifically bind to alpha(v)beta3 integrin.
    Langner J; Neumann B; Goodman SL; Pawlita M
    Arch Virol; 2004 Oct; 149(10):1877-96. PubMed ID: 15290355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of streptavidin RGD mutant on the adhesion of endothelial cells.
    Chan BP; Reichert WM; Truskey GA
    Biotechnol Prog; 2004; 20(2):566-75. PubMed ID: 15059004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW; Hota C; Shigeyama Y; D'Errico JA; Somerman MJ; Chambers AF
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of integrin-fibronectin complexes by allosteric but not ligand-mimetic inhibitors.
    Mould AP; Craig SE; Byron SK; Humphries MJ; Jowitt TA
    Biochem J; 2014 Dec; 464(3):301-13. PubMed ID: 25333419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies of the streptavidin binding loop.
    Freitag S; Le Trong I; Klumb L; Stayton PS; Stenkamp RE
    Protein Sci; 1997 Jun; 6(6):1157-66. PubMed ID: 9194176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.